AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. In 2021, the company’s top revenue generating drug was Humira. During that year Humira generated about 20.1 billion U.S. dollars in revenue for AbbVie. Humira is used to treat several types of autoimmune diseases including certain types of arthritis and Crohn’s disease. The second highest revenue generating drug for the company was Imbruvica, though it generated significantly less revenue that Humira.
AbbVie’s company profile
Abbvie was founded in 2013, originally a spin-off of Abbott Laboratories, and is based out of Chicago, Illinois, in the United States. In recent years the company has experience some growth which can also be seen in their increasing number of employees. The company has also experienced exceptional growth in their yearly revenue earnings. Finally, AbbVie has experienced significant growth in its total assets in recent years. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.
AbbVie’s global positioning
Despite being a young company, it is clear that AbbVie is among the top pharmaceutical companies. AbbVie is placed among other top companies such as Pfizer and Johnson & Johnson in terms of their prescription sales and expenditure on research and development. The company is also among the top pharmaceutical companies in terms of its net profits per employee.
AbbVie's key product revenues in 2020 and 2021
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
AbbVie. (February 18, 2022). AbbVie's key product revenues in 2020 and 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 29, 2022, from https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. "AbbVie's key product revenues in 2020 and 2021 (in million U.S. dollars)." Chart. February 18, 2022. Statista. Accessed May 29, 2022. https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. (2022). AbbVie's key product revenues in 2020 and 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 29, 2022. https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. "Abbvie's Key Product Revenues in 2020 and 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 18 Feb 2022, https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie, AbbVie's key product revenues in 2020 and 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/ (last visited May 29, 2022)
